NCT04609566 2026-03-16Brentuximab Vedotin With Pembrolizumab in Metastatic Solid TumorsSeagen Inc.Phase 2 Completed161 enrolled
NCT04254107 2025-02-10A Safety Study of SEA-TGT (SGN-TGT) in Advanced CancerSeagen Inc.Phase 1 Terminated133 enrolled